Greenlight Capital Re agrees to March 5, 2027 buyback
The Trust also reported a completed sale of 120,335 ordinary shares to the company at $15.0628 per share on October 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Greenlight Capital Re, Ltd. agreed to repurchase ordinary shares from The David M. Einhorn 2021-07 Family Trust on March 5, 2027; the number of shares and weighted average price per share are to be determined under the agreement dated October 30, 2026. The stated purpose is to reduce the likelihood of adverse tax consequences to holders due to the company’s ordinary-share repurchases.
The Trust separately sold 120,335 ordinary shares to the company at $15.0628 per share on October 30, 2026, under an agreement dated August 4, 2026. The reporting persons list shared voting and dispositive power over 6,028,320 shares for David Einhorn, a director (18.7%); 4,864,227 for DME 2022 Holdings, LLC (15.1%); and 1,164,093 for the Trust (3.6%). The percentages use 32,240,043 ordinary shares outstanding as of October 30, 2026. The reporting persons state that the reported information is not an admission of beneficial ownership and disclaim such ownership except to the extent of their pecuniary interests.
Key Figures
Key Terms
pecuniary interest regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does GLRE’s October 30, 2026 agreement with the Trust provide?
AI-generated analysis. How Rhea-AI works. Not financial advice.